Live ranking of 55 Healthcare stocks by TickerMover Alpha Score — a 0-100 composite of fundamentals, valuation, momentum, analyst signal, and macro regime. Click any ticker for the full breakdown.
| Ticker | Grade | Score | Bottom line |
|---|---|---|---|
| BIIB Biogen Inc. | A | 74 | Top-tier setup — 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned. |
| WST West Pharmaceutical Services, | A | 73 | Top-tier setup — 21% revenue growth, 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned. |
| LLY Eli Lilly and Company | A | 73 | Top-tier setup — 56% revenue growth, +13% 30-day momentum, 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned. |
| WAT Waters Corporation | A | 72 | Top-tier setup — 91% revenue growth, 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned. |
| MRNA Moderna, Inc. | A | 71 | Top-tier setup — 260% revenue growth, +28% 30-day momentum, 4/4 EPS beats. Caveat: trades 35.2% above analyst mean target. Stock i |
| HOLX Hologic, Inc. | A | 70 | Top-tier setup — 3/4 EPS beats. Momentum, fundamentals and macro indicators are aligned. |
| CRL Charles River Laboratories Int | A | 70 | Top-tier setup — +22% 30-day momentum, 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned. |
| CVS CVS Health Corporation | A | 69 | Top-tier setup — 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned. |
| DXCM DexCom, Inc. | A | 69 | Top-tier setup — 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned. |
| HUM Humana Inc. | B | 68 | Solid setup — 24% revenue growth, +19% 30-day momentum, 4/4 EPS beats. Caveat: trades 16.6% above analyst mean target. Stock is tr |
| EW Edwards Lifesciences Corporati | B | 68 | Solid setup — 3/4 EPS beats. Momentum, fundamentals and macro indicators are aligned. |
| VRTX Vertex Pharmaceuticals Incorpo | B | 68 | Solid setup — 3/4 EPS beats, 36% net margin. Momentum, fundamentals and macro indicators are aligned. |
| DGX Quest Diagnostics Incorporated | B | 67 | Solid setup — 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned. |
| CAH Cardinal Health, Inc. | B | 66 | Solid setup — +14% 30-day momentum, 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned. |
| UNH UnitedHealth Group Incorporate | B | 66 | Solid setup — 3/4 EPS beats. Momentum, fundamentals and macro indicators are aligned. |
| DVA DaVita Inc. | B | 66 | Solid setup — 3/4 EPS beats. Caveat: trades 8.7% above analyst mean target. Stock is trading above the analyst mean target ($194) |
| WBA Walgreens Boots Alliance, Inc. | B | 64 | Solid setup — 4/4 EPS beats. Caveat: only 36% of fundamentals are loaded. Some fundamental fields are missing — score has lower da |
| ILMN Illumina, Inc. | B | 64 | Solid setup — +12% 30-day momentum, 4/4 EPS beats. Caveat: trades 8.4% above analyst mean target. Stock is trading above the analy |
| A Agilent Technologies, Inc. | B | 64 | Solid setup — +11% 30-day momentum, 3/4 EPS beats. Momentum, fundamentals and macro indicators are aligned. |
| VTRS Viatris Inc. | B | 62 | Solid setup — 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned. |
| INCY Incyte Corporation | B | 62 | Solid setup — 21% revenue growth, 3/4 EPS beats, 27% net margin. Momentum, fundamentals and macro indicators are aligned. |
| CI The Cigna Group | B | 61 | Solid setup — 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned. |
| ZBH Zimmer Biomet Holdings, Inc. | B | 61 | Solid setup — 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned. |
| ABBV AbbVie Inc. | B | 61 | Solid setup — 3/4 EPS beats. Momentum, fundamentals and macro indicators are aligned. |
| LH Labcorp Holdings Inc. | B | 61 | Solid setup — 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned. |
| COR Cencora, Inc. | C | 60 | Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data. |
| ELV Elevance Health, Inc. | C | 59 | Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data. |
| JNJ Johnson & Johnson | C | 58 | Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data. |
| MRK Merck & Co., Inc. | C | 58 | Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data. |
| BAX Baxter International Inc. | C | 58 | Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data. |
| MCK McKesson Corporation | C | 57 | Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data. |
| AMGN Amgen Inc. | C | 55 | Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data. |
| MDT Medtronic plc | C | 55 | Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data. |
| DHR Danaher Corporation | C | 55 | Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data. |
| ABT Abbott Laboratories | C | 55 | Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data. |
| IDXX IDEXX Laboratories, Inc. | C | 54 | Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data. |
| BSX Boston Scientific Corporation | C | 53 | Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data. |
| TMO Thermo Fisher Scientific Inc. | C | 53 | Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data. |
| PODD Insulet Corporation | C | 53 | Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data. |
| PFE Pfizer Inc. | C | 52 | Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data. |
| AZN AstraZeneca PLC | C | 52 | Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data. |
| BMY Bristol-Myers Squibb Company | C | 52 | Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data. |
| IQV IQVIA Holdings Inc. | C | 51 | Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data. |
| BDX Becton, Dickinson and Company | C | 50 | Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data. |
| HCA HCA Healthcare, Inc. | C | 50 | Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data. |
| SYK Stryker Corporation | D | 50 | Risk is rising; momentum is fading or fundamentals are weakening. Multiple risk indicators are firing. |
| MTD Mettler-Toledo International I | D | 50 | Risk is rising; momentum is fading or fundamentals are weakening. Multiple risk indicators are firing. |
| GEHC GE HealthCare Technologies Inc | D | 49 | Risk is rising; momentum is fading or fundamentals are weakening. Multiple risk indicators are firing. |
| BIO Bio-Rad Laboratories, Inc. | D | 49 | Risk is rising; momentum is fading or fundamentals are weakening. Multiple risk indicators are firing. |
| GILD Gilead Sciences, Inc. | D | 49 | Risk is rising; momentum is fading or fundamentals are weakening. Multiple risk indicators are firing. |
Alpha Scores update every 5 minutes during US market hours. Grades: A Top Tier · B Quality · C Average · D Below Avg · F Weak. (Quality descriptors, not buy/sell recommendations.)
200+ US stocks. Alpha Score, conflict detection, Reverse DCF, peer comparison. We do the homework.
See the full live dashboard →Top-rated US stocks, conflict alerts, and Reverse-DCF reads — straight to your inbox every Sunday. Free.